CDSCO Empowers Regulators, Drives Pharma Export Boom

The Indian pharmaceutical industry is on a growth trajectory, and the CDSCO is playing a key role in its success.

311
CDSCO
CDSCO

Last Updated on September 30, 2024 by The Health Master

CDSCO

The Indian pharmaceutical industry is on a growth trajectory, and the Central Drugs Standard Control Organisation (CDSCO) is playing a key role in its success.

Through a series of strategic initiatives, CDSCO is fortifying its regulatory capabilities and enhancing the country’s pharmaceutical exports.

Building a Stronger Regulatory Framework

Enhanced Skills for Regulators:

In the 2023-24 fiscal year, CDSCO conducted 23 intensive training programs for over 1,100 regulators.

These programs focused on critical areas like risk-based inspections, legal aspects of drug regulation, and leveraging technology for Industry 4.0 compliance.

Focus on Quality and Efficiency:

The training sessions emphasized adherence to the revised Schedule M regulations, ensuring robust quality control and efficient drug approval processes.

Rigorous pre and post-assessment with a 70% pass mark guaranteed participants mastered the necessary skills.

Interactive Learning:

Beyond traditional classroom lectures, the programs incorporated dynamic group activities.

Participants formed teams of 10 to tackle real-world scenarios, fostering collaboration and knowledge exchange.

Interactive presentations by these groups enriched the learning experience.

Collaboration for Export Growth

Industry Engagement:

CDSCO recognizes the importance of industry collaboration in boosting pharmaceutical exports.

It actively participates in industry gatherings, such as a recent workshop held in Panjim, Goa.

Capacity Building for Export Success:

Organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) in collaboration with the Goa Food and Drug Administration (FDA) and CDSCO, the workshop focused on reinforcing quality compliance for exports.

India’s Growing Stature:

The workshop highlighted India’s emergence as a global pharmaceutical powerhouse. Its robust supply chain ensures patient safety and timely delivery worldwide.

India’s Pharmaceutical Strength

Resilience and Growth:

Pharmexcil Director General emphasized India’s resilient pharmaceutical supply chain, even amidst global challenges.

Export Performance:

Encouraging statistics revealed a remarkable 9% growth in pharmaceutical exports from April to February 2024.

Global Recognition:

India is a trusted source of medicines for Latin America, Europe, and Africa, solidifying its position as the world’s pharmacy.

By investing in its regulatory framework and building strong industry partnerships, CDSCO is paving the way for a thriving Indian pharmaceutical sector on the global stage.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news